Clinical Trial Update: Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chlortalidone and bumetanide in advanced chronic kidney disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• BUMETANIDE (bumetanide)
• chlortalidone (chlortalidone)

Snippet

Sponsor: Hospital General de México Dr. Eduardo Liceaga | Conditions: Renal Insufficiency, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2020-03-10